Video: Day 2 Highlights | ACC.19

Drs. Kim Eagle, Deepak Bhatt, and Peter Block discuss TAVR vs. SAVR in low-risk patients (PARTNER 3 and Evolut Low Risk - 00:39); safety evaluation of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with AFib and ACS and/or PCI (AUGUSTUS - 2:55); partial oral treatment of left-sided infectious endocarditis (POET - 4:16); and a multicenter study of MagLev technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3 - 6:25).

Keywords: ACC Annual Scientific Session, ACC19, Atrial Fibrillation, Aspirin, Acute Coronary Syndrome, Anticoagulants, Pyridones, Arrhythmias, Cardiac, Aortic Valve Stenosis, Vitamin K, Cardiac Surgical Procedures, Percutaneous Coronary Intervention, Pyrazoles, Aortic Valve Insufficiency, Heart Valve Prosthesis, Heart Failure, Geriatrics, Pacemaker, Artificial, Stroke, Vascular Diseases, Administration, Oral, Heart Valve Diseases, Transcatheter Aortic Valve Replacement, Anti-Bacterial Agents, Endocarditis, Endocarditis, Bacterial, Bacteremia, Enterococcus, Enterococcus faecalis, Primary Prevention, Staphylococcus aureus, Staphylococcal Infections, Streptococcus, Treatment Outcome, Heart, Artificial, Hemorrhage, Secondary Prevention, Reoperation, Stroke, Thrombosis, Warfarin, Vascular Diseases, Heart-Assist Devices

< Back to Listings